Literature DB >> 23131038

Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.

Shweta Kaushik1, Fernando Teque, Mira Patel, Sue H Fujimura, Barbara Schmidt, Jay A Levy.   

Abstract

In HIV-1 infection, plasmacytoid dendritic cell (PDC) numbers and function are decreased. No detailed comparisons of PDC responses to various stimuli in HIV-1-infected patients are available. Using for the first time purified PDCs, we compared PDC responses [interferon (IFN)-α production/cell] to various stimuli in a large number (n=48) of HIV-1-infected patients and healthy volunteers (n=19). Toll-like receptor (TLR)7- and TLR9-induced expression of PDC surface activation and maturation markers was also compared in the two populations. We have confirmed that PDC number coincides with CD4(+) T cell counts and clinical state. Notably, we have shown that a direct association of PDC function in terms of IFN-α production/cell exists with PDC numbers and CD4(+) cell counts when PDCs are exposed to a TLR9 ligand and HIV-infected cells, but not with a TLR7 ligand. Moreover, in the HIV-infected subjects but not the healthy controls, the magnitude of IFN-α release per PDC in response to the TLR7 ligand is significantly (p<0.01) lower than that to the TLR9 ligand. However, in both study populations, the TLR7 stimulation in comparison to TLR9 stimulation induced higher expression of PDC surface activation and maturation markers and significantly (p<0.05) decreased the expression of BDCA-2, a negative regulator of interferon. Furthermore, the cross-ligation of BDCA-2 significantly (p<0.05) inhibited TLR9- but not TLR7-induced IFN-α production by PDCs from both clinical groups. These findings suggest that differences exist in TLR7- and TLR9-induced IFN-α production by PDCs in HIV-infected individuals that are not directly related to BDCA-2 down-modulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23131038      PMCID: PMC3581027          DOI: 10.1089/aid.2012.0200

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  45 in total

1.  The nature of the principal type 1 interferon-producing cells in human blood.

Authors:  F P Siegal; N Kadowaki; M Shodell; P A Fitzgerald-Bocarsly; K Shah; S Ho; S Antonenko; Y J Liu
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

4.  Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

Authors:  Miren Kerkmann; Simon Rothenfusser; Veit Hornung; Andreas Towarowski; Moritz Wagner; Anja Sarris; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

5.  Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection.

Authors:  Karin Loré; Anders Sönnerborg; Christina Broström; Li-Ean Goh; Luc Perrin; Hugh McDade; Hans-Jürgen Stellbrink; Brian Gazzard; Rainer Weber; Laura A Napolitano; Yvette van Kooyk; Jan Andersson
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

6.  Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells.

Authors:  Akihito Yonezawa; Rimpei Morita; Akifumi Takaori-Kondo; Norimitsu Kadowaki; Toshio Kitawaki; Toshiyuki Hori; Takashi Uchiyama
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1.

Authors:  Heather Donaghy; Brian Gazzard; Frances Gotch; Steven Patterson
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

8.  Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells.

Authors:  Alexander Izaguirre; Betsy J Barnes; Sheela Amrute; Wen-Shuz Yeow; Nicholas Megjugorac; Jihong Dai; Di Feng; Eugene Chung; Paula M Pitha; Patricia Fitzgerald-Bocarsly
Journal:  J Leukoc Biol       Date:  2003-09-02       Impact factor: 4.962

Review 9.  Toll-like receptors and their signaling mechanisms.

Authors:  Shizuo Akira; Shintaro Sato
Journal:  Scand J Infect Dis       Date:  2003

10.  Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals.

Authors:  Michelle A Barron; Naomi Blyveis; Brent E Palmer; Samantha MaWhinney; Cara C Wilson
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

View more
  10 in total

1.  HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?

Authors:  Juan C Hernandez; Georges St Laurent; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

2.  Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

Authors:  Bin Su; Maryse Peressin; Camille Ducloy; Julien Penichon; Luzia M Mayr; Géraldine Laumond; Sylvie Schmidt; Thomas Decoville; Christiane Moog
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-10       Impact factor: 2.205

3.  Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques.

Authors:  Ladawan Khowawisetsut; Kovit Pattanapanyasat; Nattawat Onlamoon; Ann E Mayne; Dawn M Little; Francois Villinger; Aftab A Ansari
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART.

Authors:  Albert Font-Haro; Vaclav Janovec; Tomas Hofman; Ladislav Machala; David Jilich; Zora Melkova; Jan Weber; Katerina Trejbalova; Ivan Hirsch
Journal:  Viruses       Date:  2018-03-28       Impact factor: 5.048

Review 5.  Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection.

Authors:  Enrique Martin-Gayo; Xu G Yu
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

Review 6.  Dendritic Cells, the Double Agent in the War Against HIV-1.

Authors:  Alba Martín-Moreno; Mª Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

7.  Opiate use inhibits TLR9 signaling pathway in vivo: possible role in pathogenesis of HIV-1 infection.

Authors:  Yanyan Liao; Junjun Jiang; Bingyu Liang; Fumei Wei; Jiegang Huang; Peijiang Pan; Jinming Su; Bo Zhou; Ning Zang; Li Ye; Hao Liang
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

8.  Double methylation of tRNA-U54 to 2'-O-methylthymidine (Tm) synergistically decreases immune response by Toll-like receptor 7.

Authors:  Patrick Keller; Isabel Freund; Virginie Marchand; Guillaume Bec; Raven Huang; Yuri Motorin; Tatjana Eigenbrod; Alexander Dalpke; Mark Helm
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

9.  N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages.

Authors:  Shuliang Chen; Sameer Kumar; Constanza E Espada; Nagaraja Tirumuru; Michael P Cahill; Lulu Hu; Chuan He; Li Wu
Journal:  PLoS Pathog       Date:  2021-03-10       Impact factor: 6.823

10.  Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic.

Authors:  Saadet Inan; Nae J Dun; Alan Cowan
Journal:  Molecules       Date:  2021-09-11       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.